Elicera Therapeutics AB (ELIC.ST) Q4 2022 Earnings

17FebExpected
Q4 2022
-0.2
0.14
0.47
0.8

Details

Expected EPS
N/A
Actual EPS
-0.1971
Surprise EPS
-0.2
Surprise Percent
+∞%

Description

Elicera Therapeutics AB (ELIC.ST) has reported earnings of -0.1971 per share for Q4 2022.

0 Comments

Share your thoughts